Innovative health companies join registry to discuss psilocybin and AI-driven drug research.
This content is available to lobbymonitor.ca subscribers.
Already a subscriber?
Sign in here
The Lobby Monitor community is passionate, plugged-in and engaged in Canadian politics and policy.
Come inside the bubble. Take a free trial today.
Free Trial
